McCarthy Sean A.

McCarthy Sean A. is listed in filings as CEO at CytomX Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 19, 2026, including sale activity. Recent filings connect the profile to CytomX Therapeutics, Inc. (CTMX). The current snapshot covers public activity from Aug 22, 2024 to Mar 19, 2026. Reported amounts are shown as $17.1K to $691.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.